AnexAPep Inc.
PrivateLast Round
Seed
Jan 28, 2019
Company Overview
AnexAPep Inc. is a biotechnology company that focuses on the research and development of peptide-drug conjugates (PDCs) as novel remedies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
peptide-drug conjugatePDConcology drug discoverysolid tumor therapytargeted cancer therapybiotech licensingdrug pipelinepreclinical researchcytotoxic agentbiotech startupdrug delivery systemprecision medicinepharma partnering
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnexAPep Inc. Comparables
Compare AnexAPep Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tianjin Conjustar Biotechnology Co., Ltd. | 83% | |
| Cybrexa Therapeutics | 78% | |
| Soricimed Biopharma Inc. | 77% | |
AnexAPep Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2019
Seed round led by Daiwa Inv Co.
AnexAPep Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AnexAPep Inc.'s valuation, stock price, and market status.